Nissay Asset Management’s Charles River Laboratories CRL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-6,217	Closed	-$1.16M	–	734
2024 Q4	$1.16M	Buy	6,217 +58	+0.9%	+$11.2K	0.01%	625
2024 Q3	$1.21M	Buy	6,159 +190	+3%	+$39.5K	0.01%	625
2024 Q2	$1.23M	Buy	5,969 +128	+2%	+$29K	0.01%	599
2024 Q1	$1.58M	Buy	5,841 +92	+2%	+$22K	0.01%	561
2023 Q4	$1.36M	Buy	5,749 +223	+4%	+$43.9K	0.01%	564
2023 Q3	$1.08M	Buy	5,526 +186	+3%	+$38.2K	0.01%	593
2023 Q2	$1.12M	Sell	5,340 -36	-0.7%	-$7.16K	0.01%	585
2023 Q1	$1.08M	Sell	5,376 -181	-3%	-$41K	0.01%	583
2022 Q4	$1.21M	Sell	5,557 -111	-2%	-$24.2K	0.01%	553
2022 Q3	$1.11M	Buy	5,668 +239	+4%	+$51.6K	0.01%	561
2022 Q2	$1.16M	Sell	5,429 -168	-3%	-$41.1K	0.01%	553
2022 Q1	$1.59M	Buy	5,597 +136	+2%	+$41.9K	0.01%	522
2021 Q4	$2.06M	Buy	5,461 +107	+2%	+$41.6K	0.02%	469
2021 Q3	$2.21M	Buy	5,354 +188	+4%	+$78.1K	0.02%	433
2021 Q2	$1.91M	Buy	+5,166	New	+$1.73M	0.02%	458